Fig. 2: PFS for the included population are shown in months.
Kaplan–Meier distributions for progression-free survival in metastatic TNBC patients treated with cabozantinib and nivolumab.
Fig. 2: PFS for the included population are shown in months. | npj Breast Cancer
